I'm not expecting anything super special with the H1 Report; we already have the unaudited sales revenue for H1 (released in the "$2 million month" announcement 7 Jan) and it's unlikely that they will provide January sales.
What's more likely is that we will receive updates on things that we know are in train, e.g., sales progress, following the CE mark granting, in the UK and DACH region plus other now possible entry points across Europe.
The excitement for me comes not from any one event but the overall and relentless progress of the company.
- Forums
- ASX - By Stock
- PNV
- Another publication
Another publication, page-17
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.99 |
Change
-0.050(2.45%) |
Mkt cap ! $1.388B |
Open | High | Low | Value | Volume |
$2.02 | $2.04 | $1.99 | $1.491M | 741.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 16303 | $1.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.00 | 7174 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 686 | 1.990 |
14 | 16145 | 1.985 |
6 | 59117 | 1.980 |
9 | 22798 | 1.975 |
11 | 24808 | 1.970 |
Price($) | Vol. | No. |
---|---|---|
1.995 | 7275 | 27 |
2.000 | 16822 | 14 |
2.010 | 21064 | 14 |
2.020 | 37874 | 15 |
2.030 | 55632 | 10 |
Last trade - 14.47pm 18/11/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online